Akari Therapeutics Announces Existing Investors Support the Company Through a $2 Million Private Placement Financing

January 19, 2024

https://www.globenewswire.com/news-release/2024/01/02/2802629/0/en/Akari-Therapeutics-Announces-Existing-Investors-Support-the-Company-Through-a-2-Million-Private-Placement-Financing.html

BOSTON and LONDON, Jan. 02, 2024 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq:AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, today announced that it closed a private placement financing with existing investors, Akari Chairman Dr. Ray Prudo and Director Samir R. Patel, M.D., on December 29, 2023, resulting in gross proceeds of approximately $2 million.

Read more at globenewswire.com

Related news for (AKTX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.